Aussie manufacturing sector records slower contraction in April – Judo Bank
Australia’s manufacturing sector experienced a slight contraction in April, but the pace of deterioration was notably slower than in previous months, according to the latest data from Judo Bank's PMI report.
EMVision bags $1.75m manufacturing grant payment
Brain imaging company EMVision Medical Devices Limited has received a cash progress payment of $1,750,000 under its Modern Manufacturing Initiative (MMI) grant award.
Eurozone’s composite output eases in December amid improved supply
Eurozone’s PMI Composite Output Index saw a significant increase for the second consecutive month, increasing from November’s 47.8 to a four-month high of 48.8.
Austal launches largest ferry built at its Philippines shipyard
Shipbuilder Austal Philippines has delivered the 115-metre, high-speed vehicle-passenger ferry Express 5, the largest ferry constructed by an Austal shipyard.
Executive survey highlights tools toward operational agility
A recent study revealed that manufacturing leaders across Australia/New Zealand, Canada, Germany, Singapore, the United States, and the United Kingdom are highly concerned that...
Orbital kickstarts UAS engine delivery for Australian Army contract
Orbital UAV has begun the delivery of engine builds for Insitu Pacific’s next-generation tactical UAS for the Australian Army.
Manufacturing sector faces persistent challenges amid contraction – Ai Group
The latest Ai Group Australian Industry Index for June shows that the manufacturing sector remains in contraction, with the index rising 14.7 points to -25.6 points, marking 26 consecutive months of decline.
Anteris awarded utility patent for novel transcatheter heart valve replacement
Australian biotechnology company Anteris Technologies announced that the US Patent and Trademark Office has issued another utility patent for its novel DurAVR transcatheter heart valve (THV).
Austal’s EBIT rises to $56.5M in FY2024 amid record $12.7B order book
Austal Limited announced its financial results for the fiscal year ending 30 June 2024 (FY2024), reporting a significant turnaround with Earnings Before Interest and Tax (EBIT) of $56.5 million.
Mayne Pharma sells US retail generics portfolio for $134 million
Australian pharmaceutical manufacturing company Mayne Pharma has completed the sale of its US retail generics portfolio to Dr. Reddy’s Laboratories for approximately $134 million.
Featured Article
Delivering growth: how invoice finance transformed a logistics business
For a smaller freight-forwarding company to compete with international behemoths, Global Trade Logistics founder Gary Coutsoudis knows he and his team must outperform.
